➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Mallinckrodt
Colorcon
Harvard Business School
Merck

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

ELIXOPHYLLIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Elixophyllin, and what generic alternatives are available?

Elixophyllin is a drug marketed by Forest Labs and Nostrum Labs Inc and is included in four NDAs.

The generic ingredient in ELIXOPHYLLIN is theophylline. There are thirty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Elixophyllin

A generic version of ELIXOPHYLLIN was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Try it Free

Drug patent expirations by year for ELIXOPHYLLIN
Recent Clinical Trials for ELIXOPHYLLIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vanderbilt University Medical CenterPhase 2

See all ELIXOPHYLLIN clinical trials

Pharmacology for ELIXOPHYLLIN
Drug ClassMethylxanthine

US Patents and Regulatory Information for ELIXOPHYLLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs ELIXOPHYLLIN theophylline CAPSULE;ORAL 085545-001 Jul 31, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Forest Labs ELIXOPHYLLIN SR theophylline CAPSULE, EXTENDED RELEASE;ORAL 086826-001 Jan 29, 1985 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Forest Labs ELIXOPHYLLIN theophylline CAPSULE;ORAL 083921-001 Jul 31, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Nostrum Labs Inc ELIXOPHYLLIN theophylline SOLUTION, ELIXIR;ORAL 085186-001 Approved Prior to Jan 1, 1982 AA RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Forest Labs ELIXOPHYLLIN SR theophylline CAPSULE, EXTENDED RELEASE;ORAL 086826-002 Jan 29, 1985 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Mallinckrodt
Colorcon
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.